Citation Impact
Citing Papers
The effect of mindfulness-based therapy on anxiety and depression: A meta-analytic review.
2010 Standout
Nerve growth factor: an update on the science and therapy
2013
New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
2020 Standout
Validation of the International Classification of Functioning, Disability and Health Core Set for chronic widespread pain from the perspective of fibromyalgia patients
2009
An Overview of Animal Models of Pain: Disease Models and Outcome Measures
2013
Association of Chronic Pelvic Pain and Endometriosis With Signs of Sensitization and Myofascial Pain
2015
Fibromyalgia: a rheumatologic diagnosis?
2007
On the Clinical Pharmacology of Reactive Oxygen Species
2020
Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
2020 Standout
Fibromyalgia Syndrome Module at OMERACT 9: Domain Construct
2009
Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use
2015
Clinical Relevance of the Pharmacokinetic Interactions of Azole Antifungal Drugs with Other Coadministered Agents
2009
Non-specific low back pain
2016 Standout
Tai Chi on psychological well-being: systematic review and meta-analysis
2010 Standout
Methods Used to Evaluate Pain Behaviors in Rodents
2017 Standout
Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians
2017 Standout
Osteoarthritis
2015 Standout
Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases
2015
Anti-arthritic agents: Progress and potential
2015
Serious joint-related adverse events in randomized controlled trials of anti-nerve growth factor monoclonal antibodies
2014
<p>Pooled analysis of tanezumab efficacy and safety with subgroup analyses of phase III clinical trials in patients with osteoarthritis pain of the knee or hip</p>
2019
Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors
2011 Standout
Dengue
2012 Standout
Mindfulness Meditation for Symptom Reduction in Fibromyalgia: Psychophysiological Correlates
2009
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology
2022 Standout
Content and Criterion Validity of the Preliminary Core Dataset for Clinical Trials in Fibromyalgia Syndrome
2009
Managing severe pain and abuse potential: the potential impact of a new abuse-deterrent formulation oxycodone/naltrexone extended-release product
2018
The American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia and Measurement of Symptom Severity
2010 Standout
Clinical targeting of the TNF and TNFR superfamilies
2013
A Randomized Trial of Tai Chi for Fibromyalgia
2010 Standout
Non-specific low back pain
2011 Standout
Medication Adherence: WHO Cares?
2011 Standout
A Randomized Controlled Trial of Chloroquine for the Treatment of Dengue in Vietnamese Adults
2010
Biologic agents in osteoarthritis: hopes and disappointments
2013
Osteoarthritis
2019 Standout
Pharmacological Management of Low Back Pain
2010
Does a Single-Pill Antihypertensive/Lipid-Lowering Regimen Improve Adherence in US Managed Care Enrolees?
2010
Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons
2017 StandoutNobel
Depression, Anxiety, and Correlating Factors in Endometriosis: A Systematic Review and Meta-Analysis
2021 Standout
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
Non-steroidal anti-inflammatory drugs for chronic low back pain
2016
Effect of Tanezumab on Joint Pain, Physical Function, and Patient Global Assessment of Osteoarthritis Among Patients With Osteoarthritis of the Hip or Knee
2019
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)
2020 Standout
Diagnosis and Treatment of Hip and Knee Osteoarthritis
2021 Standout
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Efficacy and Safety of Tanezumab on Osteoarthritis Knee and Hip Pains: A Meta-Analysis of Randomized Controlled Trials
2016
What does best practice care for musculoskeletal pain look like? Eleven consistent recommendations from high-quality clinical practice guidelines: systematic review
2019 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
The mechanosensitive ion channel Piezo2 mediates sensitivity to mechanical pain in mice
2018 StandoutNobel
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Therapeutic Potential of Quercetin: New Insights and Perspectives for Human Health
2020 Standout
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout
Works of Candace Bramson being referenced
Exploring the Role of Tanezumab as a Novel Treatment for the Relief of Neuropathic Pain
2015
Efficacy and safety of tanezumab in the treatment of chronic low back pain
2011
Effects of Ethanol on the Pharmacokinetics of Extended-Release Oxycodone with Sequestered Naltrexone (ALO-02)
2015
Characterization of nitrotyrosine as a biomarker for arthritis and joint injury
2012
Bioavailability of Amlodipine Besylate/Atorvastatin Calcium Combination Tablet
2006
A randomized double-blind, placebo-controlled efficacy and safety study of ALO-02 (extended-release oxycodone surrounding sequestered naltrexone) for moderate-to-severe chronic low back pain treatment
2015
Long-term safety and effectiveness of tanezumab as treatment for chronic low back pain
2014
Effects of three cytochrome P450 inhibitors, ketoconazole, fluconazole, and paroxetine, on the pharmacokinetics of lasofoxifene
2006
Efficacy and safety of tanezumab versus naproxen in the treatment of chronic low back pain
2013
Intranasal administration of crushed ALO‐02 (extended‐release oxycodone with sequestered naltrexone): A randomized, controlled abuse‐potential study in nondependent recreational opioid users
2015
(412) Abuse potential study of ALO-02 (extended-release oxycodone surrounding sequestered naltrexone) compared with immediate-release oxycodone administered orally to non-dependent, recreational opioid users
2014
Abuse Potential Study of ALO-02 (Extended-Release Oxycodone Surrounding Sequestered Naltrexone) Compared with Immediate-Release Oxycodone Administered Orally to Nondependent Recreational Opioid Users
2016
Tanezumab, an Anti-Nerve Growth Factor (NGF) antibody, for the treatment of chronic low back pain (CLBP) – a randomized, controlled, double-blind, phase 2 trial
2009
Fibromyalgia syndrome.
2005
LACK OF A PHARMACOKINETIC INTERACTION BETWEEN AZITHROMYCIN AND CHLOROQUINE
2006